- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Benzoyl Peroxide and Retinol Regimen is Effective for Acne Vulgaris
![Benzoyl Peroxide and Retinol Regimen is Effective for Acne Vulgaris Benzoyl Peroxide and Retinol Regimen is Effective for Acne Vulgaris](https://medicaldialogues.in/h-upload/2021/04/26/750x450_151642-acne-vulgaris.webp)
Benzoyl peroxide is an FDA approved skincare ingredient that's widely used for the topical treatment of acne. In a recent study presented at the American Academy of Dermatology (AAD) Virtual Meeting Experience, the researchers have reported that the combination of 2.5 benzoyl peroxide and a stabilized cosmetic retinol significantly improves lesion count reduction after 12 weeks.
The first-line topical treatment for mild to moderate acne that dermatologists recommend is a combination of benzoyl peroxide (BPO) to target the bacteria, and a retinoid, to promote surface cell turnover. Researchers of Johnson & Johnson conducted a study to evaluate the efficacy and tolerance of a daily regimen of 2.5% BPO and a stabilized cosmetic retinol for its ability to improve acne and overall complexion in patients (aged 12-30) with mild to moderate acne.
It was a 12-week, multi-centre, evaluator-blinded clinical study with 33 participants with mild to moderate acne vulgaris on the face. All patients had between 10-100 non-inflammatory plus 10-50 inflammatory lesions. The researchers used Investigator Global Acne (IGA) assessment in addition to other efficacy assessments and self-assessments. The major outcome assessed was a per cent change from baseline to week 12 in total lesion counts. During the course of the study period, patients applied benzoyl peroxide in the morning and cosmetic retinol in the evening (each only once daily) for 12 weeks.
Key findings of the study were:
- Within 1 week, the researchers noted that about 84.2% of patients in the regimen experienced an average reduction of 18.6% total lesion counts compared to baseline.
- They also noted that 34.2% of patients reported a 10.5% improvement in IGA within the same time period.
- By week 4, they observed a 35.2% average reduction in total lesion count in94.3% of patients, with 71.4% reporting an average 28.8 improvement in IGA.
- By week 12 they found 100% improvement in all patients and a lesion count reduction of 54.2%. As many as 84.8% reported an average of 44.3% improvement in IGA.
The authors concluded, "Thus, this unique benzoyl peroxide and retinol regimen offer patients a multi-mechanism OTC option for addressing the disease state acne lesions along with the complexion endpoints like pigmentation, redness, and overall tone evenness."
For further information:
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751